The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Riley, Lisa G.
  • dc.contributor.author Arenillas Rocha, Leonor
  • dc.contributor.author Fleming, Mark D.
  • dc.date.accessioned 2019-05-09T06:47:10Z
  • dc.date.available 2019-05-09T06:47:10Z
  • dc.date.issued 2018
  • dc.description.abstract YARS2 variants have previously been described in patients with myopathy, lactic acidosis and sideroblastic anemia 2 (MLASA2). YARS2 encodes the mitochondrial tyrosyl-tRNA synthetase, which is responsible for conjugating tyrosine to its cognate mt-tRNA for mitochondrial protein synthesis. Here we describe 14 individuals from 11 families presenting with sideroblastic anemia and YARS2 variants that we identified using a sideroblastic anemia gene panel or exome sequencing. The phenotype of these patients ranged from MLASA to isolated congenital sideroblastic anemia. As in previous cases, inter- and intra-familial phenotypic variability was observed, however, this report includes the first cases with isolated sideroblastic anemia and patients with biallelic YARS2 variants that have no clinically ascertainable phenotype. We identified ten novel YARS2 variants and three previously reported variants. In vitro amino-acylation assays of five novel missense variants showed that three had less effect on the catalytic activity of YARS2 than the most commonly reported variant, p.(Phe52Leu), associated with MLASA2, which may explain the milder phenotypes in patients with these variants. However, the other two missense variants had a more severe effect on YARS2 catalytic efficiency. Several patients carried the common YARS2 c.572 G>T, p.(Gly191Val) variant (minor allele frequency =0.1259) in trans with a rare deleterious YARS2 variant. We have previously shown that the p.(Gly191Val) variant reduces YARS2 catalytic activity. Consequently, we suggest that biallelic YARS2 variants, including severe loss-of-function alleles in trans of the common p.(Gly191Val) variant, should be considered as a cause of isolated congenital sideroblastic anemia, as well as the MLASA syndromic phenotype.
  • dc.description.sponsorship This research was funded by grants from Instituto de Salud Carlos III (ISCIII) PI14/01867, PI16/02024 and PI17/00701, TRASCAN (EPICA), CIBERONC (CB16/12/00489; Co-finance with FEDER funds), RTICC (RD12/0036/0068) and Departamento de Salud del Gobierno de Navarra 40/2016. N.M. is supported by a FEHH-Celgene research grant, M.P. was supported by a Sara Borrell fellowship CD12/00540 and RO was supported by Ministerio de Ciencia, Innovación y Universidades of Spain, Subprograma de Formación de Profesorado Universitario (FPU) award number FPU14/04331.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Riley LG, Heeney MM, Rudinger-Thirion J, Frugier M, Campagna DR, Zhou R. et al. The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica. 2018 Dec;103(12):2008-2015. DOI: 10.3324/haematol.2017.182659
  • dc.identifier.doi http://dx.doi.org/10.3324/haematol.2017.180505
  • dc.identifier.issn 0390-6078
  • dc.identifier.uri http://hdl.handle.net/10230/37193
  • dc.language.iso eng
  • dc.publisher Ferrata Storti Foundation
  • dc.relation.ispartof Haematologica. 2018 Dec;103(12):2008-15
  • dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/SAF2015-70412-R
  • dc.rights ©2018 Ferrata Storti Foundation. Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legal code. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legal code, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
  • dc.subject.other Anèmia
  • dc.subject.other Fenotip
  • dc.title The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions

Articles (Hospital del Mar Research Institute)